Cargando…
Arterial hypertension and the risk of severity and mortality of COVID-19
Arterial hypertension implies the risk of a hard COVID-19 outcome. This may be explained by potential confounding factors, such as age and cardiovascular disease. https://bit.ly/2Kr6Ax4
Autores principales: | Leiva Sisnieguez, Carlos Enrique, Espeche, Walter Gastón, Salazar, Martín Rogelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236824/ https://www.ncbi.nlm.nih.gov/pubmed/32398296 http://dx.doi.org/10.1183/13993003.01148-2020 |
Ejemplares similares
-
Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
por: Riera, Jordi, et al.
Publicado: (2022) -
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020) -
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020) -
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020) -
Potential of regulatory T-cell-based therapies in the management of severe COVID-19
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2020)